Logo

American Heart Association

  23
  0


Final ID: MP297

Sex Differences in Left Ventricular Remodeling after Transcatheter Mitral Valve Repair

Abstract Body (Do not enter title and authors here): Introduction: Left ventricular (LV) reverse remodeling after mitral transcatheter edge-to-edge repair (MTEER) is a well-observed phenomenon. However, there is limited and variable evidence regarding whether men and women experience comparable patterns of reverse remodeling.

Aim: To assess changes in LV geometry and elucidate sex differences in remodeling following MTEER.

Methods: This single-center retrospective study included consecutive adult patients who underwent MTEER with MitraClip from 2021-2022 and received comprehensive echocardiography at both baseline (prior to procedure) and follow-up (both 30 days and 1 year post-procedure). Baseline echocardiographic, demographic, and clinical data were compared between sexes. Changes in 30-day and 1-year LV diameter, volume, and mass were compared within each sex to baseline data via paired t-tests.

Results: Out of 95 patients who underwent MTEER with complete echo data, 46 (47.4%) were men and 49 (50.5%) were women. Women were older than men at the time of procedure (79.3 vs. 83.3 years, p=0.017). There were no other significant differences in relevant co-morbidities or LV function and geometry on baseline echo. Both sexes saw a significant decrease in LVEDVi at 1 year (88.8 to 84.1 mL/m2, p=0.031 in men; 70.2 to 58.2 mL/m2, p=0.008 in women). Women had significantly decreased LVESVi (34.0 to 28.6 mL/m2, p=0.033) and LVMi (113.2 to 96.8 g/m2, p=0.041) at 1 year, while men did not. Men had decreases in LVEDD (5.62 to 5.35 cm, p=0.033) and LVESD (4.35 to 3.82 cm, p=0.006) at 30 days; the reduction in LVEDD remained significant at 1 year (5.62 to 5.36 cm, p=0.004).

Conclusions: Both men and women demonstrated reverse remodeling after MTEER; these changes varied between sexes by specific echo parameters and time course. Women had reduced LVMi and LVESVi one year after MitraClip, whereas men did not. Men experienced earlier reductions in LV diameter; however only one marker of LV diameter (LVEDD) saw sustained reduction at one year. Larger studies are necessary to confirm our findings.
  • Galvani, Eileen  ( Mount Sinai Hospital , New York , New York , United States )
  • Lerakis, Stamatios  ( Mount Sinai Hospital , New York , New York , United States )
  • Naraparaju, Ankita  ( Mount Sinai Hospital , New York , New York , United States )
  • Sharma, Akarsh  ( Mount Sinai Hospital , New York , New York , United States )
  • Prakash, Yash  ( Mount Sinai Hospital , New York , New York , United States )
  • Kim, Eric  ( Mount Sinai Hospital , New York , New York , United States )
  • Mannina, Carlo  ( Mount Sinai Morningside , New York , New York , United States )
  • Tang, Gilbert  ( Mount Sinai Hospital , New York , New York , United States )
  • Sharma, Samin  ( Mount Sinai Hospital , New York , New York , United States )
  • Kini, Annapoorna  ( Mount Sinai Hospital , New York , New York , United States )
  • Author Disclosures:
    Eileen Galvani: DO NOT have relevant financial relationships | stamatios lerakis: DO NOT have relevant financial relationships | Ankita Naraparaju: No Answer | Akarsh Sharma: No Answer | Yash Prakash: DO NOT have relevant financial relationships Carlo Mannina: DO NOT have relevant financial relationships | Gilbert Tang: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Advisor:Boston Scientific:Active (exists now) ; Consultant:Shenqi Medical Technologies:Active (exists now) ; Consultant:Peija Medical:Active (exists now) ; Speaker:Siemens Healthineers:Past (completed) ; Consultant:Philips:Active (exists now) ; Consultant:Shockwave Medical:Active (exists now) ; Speaker:Edwards Lifesciences:Active (exists now) ; Consultant:Edwards Lifesciences:Active (exists now) ; Advisor:Abbott Structural Heart:Active (exists now) ; Speaker:Abbott Structural Heart:Active (exists now) ; Consultant:Abbott Structural Heart:Active (exists now) ; Advisor:Medtronic:Active (exists now) ; Speaker:Medtronic:Active (exists now) | Samin Sharma: DO NOT have relevant financial relationships | Annapoorna Kini: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Hidden Risks, Emerging Tools: Imaging and Biomarkers in Personalized CV Health

Saturday, 11/08/2025 , 09:15AM - 10:15AM

Moderated Digital Poster Session

More abstracts on this topic:
Mitral Transcatheter Edge-to-Edge Repair to Treat Systolic Anterior Motion of the Mitral Valve and a Flail Posterior Mitral Leaflet: One Clip, Two Solutions

Ravindra Krishna, Anderson Ella, Morford Reagan, Moore Ashley, Kaddaha Firas, Tavaf-motamen Houman, Kanda Brinder

Hemodynamic Insights Using Pressure Volume Loops into Transcatheter Repair Effects on Left Ventricular Function in Patients with Primary Mitral Regurgitation

Nagueh Sherif, Pournazari Payam, Wessly Priscilla, Hatab Taha, Bhimaraj Arvind, Faza Nadeen, Little Stephen, Goel Sachin

More abstracts from these authors:
Impact of Atrial Fibrillation in Patients with Severe Mitral Regurgitation Undergoing Transcatheter Edge-To-Edge Repair

Mannina Carlo, Dangas George, Halperin Jonathan, Tang Gilbert, Sharma Samin, Kini Annapoorna, Stone Gregg, Lerakis Stamatios, Sharma Akarsh, Prakash Yash, Carbone Andreina, Bossone Eduardo, Tuttolomondo Antonino, Argulian Edgar, Khera Sahil, Krishnamoorthy Parasuram

Association of Systemic Inflammatory Response Syndrome with Cardiovascular Events after Mitral Transcatheter Edge-to-edge Repair

Mannina Carlo, Sharma Samin, Kini Annapoorna, Lerakis Stamatios, Sharma Akarsh, Carbone Andreina, Bossone Eduardo, Tuttolomondo Antonino, Argulian Edgar, Neibart Eric, Halperin Jonathan, Dangas George

You have to be authorized to contact abstract author. Please, Login
Not Available